Settlements in four DOJ investigations to cost Genesis $52.7 million
By
Phil Brahm
Sep 05, 2016
Genesis Healthcare will pay $52.7 million under an agreement to settle four separate Department of Justice investigations, the nation’s largest long-term care company said.
New treatment may prevent antibiotic-resistant facility ‘superbugs’
By
Phil Brahm
Aug 02, 2016
A first-of-its-kind treatment to prevent bacterial skin infections could play a vital role in the fight against “superbugs” in healthcare facilities, a new study finds.
Successful LTC is hidden in the headlines
By
Phil Brahm
Aug 10, 2016
Over the course of my past 12 weeks as McKnight’s summer editorial intern, I’ve covered a wide variety of stories, many of which I never expected to see in long-term care.